Soc. Generale Call 39.91 OMV 21.0.../ DE000SU778T6 /
6/5/2024 1:07:56 PM | Chg.+0.020 | Bid5:28:42 PM | Ask1:14:59 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.540EUR | +3.85% | - Bid Size: - |
- Ask Size: - |
OMV AG | 39.91 - | 3/21/2025 | Call |
GlobeNewswire
3/26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
10/13/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
euro adhoc
7/28/2021
EANS-Tip Announcement: OMV Aktiengesellschaft / Half-year financial report according to art. 125 par...
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center